相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Eric Letouze et al.
CANCER CELL (2013)
CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma
Aikseng Ooi et al.
CANCER RESEARCH (2013)
The Proto-oncometabolite Fumarate Binds Glutathione to Amplify ROS-Dependent Signaling
Lucas B. Sullivan et al.
MOLECULAR CELL (2013)
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels
Daniel A. Pollyea et al.
LEUKEMIA & LYMPHOMA (2013)
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
G. M. Tannahill et al.
NATURE (2013)
Silencing a Metabolic Oncogene
Jiyeon Kim et al.
SCIENCE (2013)
(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
Julie-Aurore Losman et al.
SCIENCE (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang et al.
SCIENCE (2013)
Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor
J. Keith Killian et al.
CANCER DISCOVERY (2013)
A Role for Cytosolic Fumarate Hydratase in Urea Cycle Metabolism and Renal Neoplasia
Julie Adam et al.
CELL REPORTS (2013)
Inhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency
Nicola Ternette et al.
CELL REPORTS (2013)
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
Liang Zheng et al.
CANCER & METABOLISM (2013)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Yoichiro Mitsuishi et al.
CANCER CELL (2012)
Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
Ralph J. DeBerardinis et al.
CELL (2012)
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki et al.
GENES & DEVELOPMENT (2012)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Mengtao Xiao et al.
GENES & DEVELOPMENT (2012)
Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation
Roberta Leonardi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group
Verena I. Gaidzik et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Progress in understanding 2-hydroxyglutaric acidurias
Martijn Kranendijk et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
Whitney B. Pope et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Almut Schulze et al.
NATURE (2012)
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Masato Sasaki et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans
Wei Ge et al.
NATURE CHEMICAL BIOLOGY (2012)
HIF-α: pro- and antitumorigenic?
Regina M. Young et al.
NATURE MEDICINE (2012)
2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas
Changho Choi et al.
NATURE MEDICINE (2012)
Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production
P. S. Ward et al.
ONCOGENE (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
Systems Biology, Metabolomics, and Cancer Metabolism
Masaru Tomita et al.
SCIENCE (2012)
Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation
Mohit Jain et al.
SCIENCE (2012)
Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy
Ovidiu C. Andronesi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas
Adam Elkhaled et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Genetically-defined metabolic reprogramming in cancer
Andrew R. Mullen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
The emerging role of fumarate as an oncometabolite
Ming Yang et al.
FRONTIERS IN ONCOLOGY (2012)
SDH mutations in cancer
Chiara Bardella et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma
Aikseng Ooi et al.
CANCER CELL (2011)
Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
Julie Adam et al.
CANCER CELL (2011)
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
Toshio Suda et al.
CELL STEM CELL (2011)
Succination of proteins in diabetes
Norma Frizzell et al.
FREE RADICAL RESEARCH (2011)
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Yoshihiro Inami et al.
JOURNAL OF CELL BIOLOGY (2011)
SDHA Immunohistochemistry Detects Germline SDHA Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas
Esther Korpershoek et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Inborn and acquired metabolic defects in cancer
Christian Frezza et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients
Philippe Metellus et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Value and Limitations of Immunohistochemistry and Gene Sequencing for Detection of the IDH1-R132H Mutation in Diffuse Glioma Biopsy Specimens
Matthias Preusser et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Seeing the smoking gun: a sensitive and specific method to visualize loss of the tumour suppressor, fumarate hydratase, in human tissues
Patrick H. Maxwell
JOURNAL OF PATHOLOGY (2011)
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella et al.
JOURNAL OF PATHOLOGY (2011)
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
M. Fernanda Amary et al.
JOURNAL OF PATHOLOGY (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
Christian Frezza et al.
NATURE (2011)
Identification of lysine succinylation as a new post-translational modification
Zhihong Zhang et al.
NATURE CHEMICAL BIOLOGY (2011)
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Zachary J. Reitman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value
Saman Abbas et al.
BLOOD (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Hypoxia Signaling in Hematopoietic Stem Cells: A Double-Edged Sword
Patrick J. Pollard et al.
CELL STEM CELL (2010)
Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
Jean-Pierre Bayley et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism
Linda O'Flaherty et al.
HUMAN MOLECULAR GENETICS (2010)
IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
Peter Paschka et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
Stefan Gross et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (vol 462, pg 739, 2010)
Lenny Dang et al.
NATURE (2010)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria
Martijn Kranendijk et al.
SCIENCE (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
Francien H. van Nederveen et al.
LANCET ONCOLOGY (2009)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
Metabolic Enzymes as Oncogenes or Tumor Suppressors
Craig B. Thompson
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
John D. Hayes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Dual roles of Nrf2 in cancer
Alexandria Lau et al.
PHARMACOLOGICAL RESEARCH (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Loss of the SdhB, but not the SdhA subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis
Robert D. Guzy et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes - Formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress
Matthew Blatnik et al.
DIABETES (2008)
Succination of protein thiols during adipocyte maturation - A biomarker of mitochondrial stress
Ryoji Nagai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2
Zheng Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Mutation of succinate dehydrogenase subunit C results in increased O2•-, oxidative stress, and genomic instability
Benjamin G. Slane et al.
CANCER RESEARCH (2006)
Adult Leydig cell tumors of the testis caused by germline fumarate hydratase mutations
Luis G. Carvajal-Carmona et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption
Tomoyoshi Soga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
S-(2-succinyl)cysteine:: A novel chemical modification of tissue proteins by a Krebs cycle intermediate
Nathan L. Alderson et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
D-2-Hydroxyglutaric aciduria: Unravelling the biochemical pathway and the genetic defect
EA Struys
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Increased risk of cancer in patients with fumarate hydratase germline mutation
H. J. Lehtonen et al.
JOURNAL OF MEDICAL GENETICS (2006)
Mitochondrial succinate is instrumental for HIF1α nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions
JJ Brière et al.
HUMAN MOLECULAR GENETICS (2005)
Mitochondrial tumour suppressors: A genetic and biochemical update
E Gottlieb et al.
NATURE REVIEWS CANCER (2005)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Quantitative metabolome analysis using capillary electrophoresis mass spectrometry
T Soga et al.
JOURNAL OF PROTEOME RESEARCH (2003)
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency
NA Alam et al.
HUMAN MOLECULAR GENETICS (2003)
Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma
AP Gimenez-Roqueplo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway
AP Gimenez-Roqueplo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Inherited susceptibility to uterine leiomyomas and renal cell cancer
V Launonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
FDG-PET as a prognostic factor in high-grade astrocytoma
O De Witte et al.
JOURNAL OF NEURO-ONCOLOGY (2000)